Coronavirus Reverberates Throughout Health Care Industry

Ballard Spahr LLP

Ballard Spahr LLP

With the spread of COVID-19, barriers to testing, treating, and getting paid for coronavirus-related care and containment efforts are being identified and addressed by federal and state regulators on a daily basis. Most recently,

  • the Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, approving $8.3 billion in federal funds to address the conoravirus emergency, signed into law on March 6, included provisions easing restrictions on physicians and licensed health care practitioners treating existing patients through telehealth services;
  • the State of California declared coronavirus testing a preventive health service, prohibiting copayments from plan members and insureds for diagnostic tests; and
  • the Centers for Medicare and Medicaid announced that it was diverting all survey and accreditation services to institutional infection control surveys, requiring hospitals and health care facilities to review and implement infection control processes and issued additional memoranda on reimbursement issues.

The firm’s Health Care Group is monitoring these developments and advising clients across the industry on regulatory and transactional matters, including health benefits.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Ballard Spahr LLP | Attorney Advertising

Written by:

Ballard Spahr LLP

Ballard Spahr LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.